Techinvention Lifecare Pvt Ltd

Techinvention has enabled multiple successful biotech projects globally—especially in developing countries—by providing turnkey solutions from concept to commercialization. It is currently running at least one Phase 3 clinical trial comparing varicella vaccines and has established itself as a leader in affordable access to high-end biotech products such as vaccines and biotherapeutics. The company recently won the Dun & Bradstreet 'Start-up 50: Trailblazers Award' recognizing its impact on healthcare innovation. Its partnership with Quantoom Biosciences aims to establish India’s first EU-GMP-ready end-to-end mRNA production capability by late 2025.